ONCT insider filings

Oncternal Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-06-24. Screen ONCT transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for ONCT between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Oncternal Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2024-06-244THEUER CHARLES — DirectorGrant/award (A): 2,200 (derivative) @ $0EDGAR
2024-06-244DeSimone Jill — DirectorGrant/award (A): 2,200 (derivative) @ $0EDGAR
2024-06-244CARTER MICHAEL G — DirectorGrant/award (A): 2,200 (derivative) @ $0EDGAR
2024-06-244Wills Robert James — DirectorGrant/award (A): 2,200 (derivative) @ $0EDGAR
2024-06-244LARUE WILLIAM R — DirectorGrant/award (A): 2,200 (derivative) @ $0EDGAR
2024-06-244MAZANET ROSEMARY — DirectorGrant/award (A): 2,200 (derivative) @ $0EDGAR
2024-06-244KISNER DANIEL L — DirectorGrant/award (A): 2,200 (derivative) @ $0EDGAR
2024-06-244HALE DAVID F — DirectorGrant/award (A): 3,300 (derivative) @ $0EDGAR
2024-04-104Wills Robert James — DirectorPurchase (P): 3,086 @ $8.96EDGAR
2024-04-014Wills Robert James — DirectorPurchase (P): 6,914 @ $8.48EDGAR
2024-02-274Wills Robert James — DirectorSale (S): 980 @ $9.04EDGAR
2024-02-274HALE DAVID F — DirectorPurchase (P): 714 @ $9.04 · Purchase (P): 266 @ $9.04EDGAR
2024-02-154Leavitt Chase C. — General Counsel/SecretaryGrant/award (A): 14,200 (derivative) @ $0EDGAR
2024-02-154Krishnan Rajesh — CTO/CSOGrant/award (A): 17,700 (derivative) @ $0EDGAR
2024-02-154Yazji Salim — Chief Medical OfficerGrant/award (A): 14,200 (derivative) @ $0EDGAR
2024-02-154VINCENT RICHARD G — Chief Financial OfficerGrant/award (A): 14,200 (derivative) @ $0EDGAR
2024-02-154BREITMEYER JAMES B — Chief Executive Officer, DirectorGrant/award (A): 28,400 (derivative) @ $0 · Grant/award (A): 6,200 (derivative) @ $0EDGAR
2024-01-054Krishnan Rajesh — Chief Technical OfficerTax withholding (F): 11,838 @ $0.50EDGAR
2024-01-054Yazji Salim — Chief Medical OfficerTax withholding (F): 19,742 @ $0.50EDGAR
2024-01-054VINCENT RICHARD G — Chief Financial OfficerTax withholding (F): 8,868 @ $0.50EDGAR
2024-01-054Leavitt Chase C. — General Counsel/SecretaryTax withholding (F): 11,838 @ $0.50EDGAR
2024-01-054BREITMEYER JAMES B — Chief Executive Officer, DirectorTax withholding (F): 50,955 @ $0.50 · Tax withholding (F): 4,485 @ $0.50EDGAR
2023-10-044Leavitt Chase C. — General Counsel/SecretaryDisposition to issuer (D): 65,000 (derivative) · Disposition to issuer (D): 55,519 (derivative) · Disposition to issuer (D): 28,750 (derivative) · Disposition to issuer (D): 210,000 (derivative) · Grant/award (A): 65,000 (derivative) · Grant/award (A): 55,519 (derivative) · +3 moreEDGAR
2023-10-044Yazji Salim — Chief Medical OfficerDisposition to issuer (D): 354,400 (derivative) · Disposition to issuer (D): 92,075 (derivative) · Disposition to issuer (D): 55,000 (derivative) · Disposition to issuer (D): 210,000 (derivative) · Grant/award (A): 354,400 (derivative) · Grant/award (A): 92,075 (derivative) · +3 moreEDGAR
2023-10-044VINCENT RICHARD G — Chief Financial OfficerDisposition to issuer (D): 75,000 (derivative) · Disposition to issuer (D): 35,120 (derivative) · Disposition to issuer (D): 280,000 (derivative) · Disposition to issuer (D): 109,579 (derivative) · Disposition to issuer (D): 28,750 (derivative) · Disposition to issuer (D): 210,000 (derivative) · +6 moreEDGAR
2023-10-044Krishnan Rajesh — Chief Technical OfficerDisposition to issuer (D): 75,000 (derivative) · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 12,470 (derivative) · Disposition to issuer (D): 160,000 (derivative) · Disposition to issuer (D): 177,050 (derivative) · Disposition to issuer (D): 28,750 (derivative) · +8 moreEDGAR
2023-10-044BREITMEYER JAMES B — Chief Executive Officer, DirectorDisposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 66,890 (derivative) · Disposition to issuer (D): 750,000 (derivative) · Disposition to issuer (D): 637,000 (derivative) · Disposition to issuer (D): 123,750 (derivative) · Disposition to issuer (D): 650,000 (derivative) · +18 moreEDGAR
2023-07-054Leavitt Chase C. — General Counsel/SecretaryTax withholding (F): 10,305 @ $0.36EDGAR
2023-07-054VINCENT RICHARD G — Chief Financial OfficerTax withholding (F): 7,069 @ $0.36EDGAR
2023-07-054Yazji Salim — Chief Medical OfficerTax withholding (F): 16,299 @ $0.36EDGAR
2023-07-054Krishnan Rajesh — Chief Technology OfficerTax withholding (F): 10,897 @ $0.36EDGAR
2023-07-054BREITMEYER JAMES B — Chief Executive Officer, DirectorTax withholding (F): 47,992 @ $0.36 · Tax withholding (F): 4,007 @ $0.36EDGAR
2023-06-304THEUER CHARLES — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2023-06-304CARTER MICHAEL G — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2023-06-304Nakanishi Xin — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2023-06-304Wills Robert James — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2023-06-304LARUE WILLIAM R — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2023-06-304MAZANET ROSEMARY — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2023-06-304DeSimone Jill — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2023-06-304KISNER DANIEL L — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2023-06-304HALE DAVID F — DirectorGrant/award (A): 37,500 (derivative) @ $0EDGAR
2023-06-144Kaufmann Gunnar F. — Chief Scientific OfficerPurchase (P): 25,000 @ $0.35 · Purchase (P): 3,000 @ $0.36EDGAR
2023-04-174BREITMEYER JAMES B — Chief Executive Officer, DirectorPurchase (P): 100,000 @ $0.29 · Purchase (P): 47,750 @ $0.30 · Purchase (P): 2,250 @ $0.29EDGAR
2023-04-144Yazji Salim — Chief Medical OfficerPurchase (P): 10,000 @ $0.28 · Purchase (P): 10,000 @ $0.28 · Purchase (P): 5,000 @ $0.30EDGAR
2023-04-144Leavitt Chase C. — General Counsel/SecretaryPurchase (P): 15,000 @ $0.29 · Purchase (P): 10,000 @ $0.29EDGAR
2023-04-144VINCENT RICHARD G — Chief Financial OfficerPurchase (P): 30,000 @ $0.30EDGAR
2023-02-244BREITMEYER JAMES B — Chief Executive Officer, DirectorGrant/award (A): 650,000 (derivative) @ $0 · Grant/award (A): 65,000 (derivative) @ $0 · Grant/award (A): 42,196 (derivative) @ $0EDGAR
2023-02-234Kaufmann Gunnar F. — Chief Scientific OfficerGrant/award (A): 210,000 (derivative) @ $0EDGAR
2023-02-234VINCENT RICHARD G — Chief Financial OfficerGrant/award (A): 210,000 (derivative) @ $0EDGAR
2023-02-234Krishnan Rajesh — Chief Technology OfficerGrant/award (A): 220,000 (derivative) @ $0EDGAR

Recent 8-K events — Oncternal Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2024-11-258-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2024-11-148-K?
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
EDGAR
2024-09-128-K?
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
EDGAR
2024-08-088-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2024-06-218-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2024-05-098-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2024-03-078-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2024-01-238-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2024-01-058-K2.02 — Results of Operations and Financial Condition
3.03 — Material Modification to Rights of Security Holders
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-098-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ONCT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs